1. Prospective Design of Anti‐Transferrin Receptor Bispecific Antibodies for Optimal Delivery into the Human Brain. (17th May 2016) Authors: Kanodia, JS; Gadkar, K; Bumbaca, D; Zhang, Y; Tong, RK; Luk, W; Hoyte, K; Lu, Y; Wildsmith, KR; Couch, JA; Watts, RJ; Dennis, MS; Ernst, JA; Scearce‐Levie, K; Atwal, JK; Ramanujan, S; Joseph, S Journal: CPT: pharmacometrics & systems pharmacology Issue: Volume 5:Number 5(2016:May) Page Start: 283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial. Issue 10191 (29th June 2019) Authors: Al-Shahi Salman, Rustam; Dennis, MS; Sandercock, PAG; Sudlow, CLM; Wardlaw, JM; Whiteley, WN; Murray, GD; Stephen, J; Newby, DE; Sprigg, N; Werring, DJ; White, PM; Baigent, Colin; Lasserson, Daniel; Sullivan, Frank; Carrie, Johanna; Rojas, Javier; Amoils, Shannon; Bamford, John; Armitage, Jane Journal: Lancet Issue: Volume 393:Issue 10191(2019) Page Start: 2613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗